Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna S Shewach

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
It's what's inside that countsDonna S Shewach, Theodore S Lawrence
Cancer Chemotherapy and Pharmacology|June 18, 2003
The role of DNA synthesis inhibition in the cytotoxicity of 2',2'-difluoro-2'-deoxycytidineLeo J Ostruszka, Donna S Shewach
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2016
Detection of Nucleotide Disbalance in Cells Undergoing Oncogene-Induced SenescenceMikhail A Nikiforov, Donna S Shewach
Chemical Reviews|July 9, 2009
Introduction to cancer chemotherapeuticsDonna S Shewach, Robert D Kuchta
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2005
In vitro and in vivo enhancement of ganciclovir-mediated bystander cytotoxicity with gemcitabinePaul D Boucher, Donna S Shewach
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Antimetabolite radiosensitizersDonna S Shewach, Theodore S Lawrence
The Journal of Biological Chemistry|July 3, 2002
Nucleotide binding states of hsp70 and hsp90 during sequential steps in the process of glucocorticoid receptor.hsp90 heterocomplex assemblyKimon C Kanelakis, Donna S Shewach, William B Pratt
Cancer Research|April 6, 2006
Hydroxyurea induces bystander cytotoxicity in cocultures of herpes simplex virus thymidine kinase-expressing and nonexpressing HeLa cells incubated with ganciclovirBrian G Gentry, Paul D Boucher, Donna S Shewach
Seminars in Oncology|June 17, 2004
Promising combination therapies with gemcitabineBlaine W Robinson, Leo Ostruszka, Michael M Im, et al.
Molecular Cancer Therapeutics|June 19, 2007
Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: a new paradigm for antimetabolite radiosensitizersSheryl A Flanagan, Blaine W Robinson, Christina M Krokosky, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
It's what's inside that countsDonna S Shewach, Theodore S Lawrence
Cancer Chemotherapy and Pharmacology|June 18, 2003
The role of DNA synthesis inhibition in the cytotoxicity of 2',2'-difluoro-2'-deoxycytidineLeo J Ostruszka, Donna S Shewach
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2016
Detection of Nucleotide Disbalance in Cells Undergoing Oncogene-Induced SenescenceMikhail A Nikiforov, Donna S Shewach
Chemical Reviews|July 9, 2009
Introduction to cancer chemotherapeuticsDonna S Shewach, Robert D Kuchta
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2005
In vitro and in vivo enhancement of ganciclovir-mediated bystander cytotoxicity with gemcitabinePaul D Boucher, Donna S Shewach
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Antimetabolite radiosensitizersDonna S Shewach, Theodore S Lawrence
The Journal of Biological Chemistry|July 3, 2002
Nucleotide binding states of hsp70 and hsp90 during sequential steps in the process of glucocorticoid receptor.hsp90 heterocomplex assemblyKimon C Kanelakis, Donna S Shewach, William B Pratt
Cancer Research|April 6, 2006
Hydroxyurea induces bystander cytotoxicity in cocultures of herpes simplex virus thymidine kinase-expressing and nonexpressing HeLa cells incubated with ganciclovirBrian G Gentry, Paul D Boucher, Donna S Shewach
Seminars in Oncology|June 17, 2004
Promising combination therapies with gemcitabineBlaine W Robinson, Leo Ostruszka, Michael M Im, et al.
Molecular Cancer Therapeutics|June 19, 2007
Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: a new paradigm for antimetabolite radiosensitizersSheryl A Flanagan, Blaine W Robinson, Christina M Krokosky, et al.
Pageof 3